{"id":"solution-for-peritoneal-dialysis","safety":{"commonSideEffects":[{"rate":"null","effect":"Peritonitis"},{"rate":"null","effect":"Electrolyte imbalance"},{"rate":"null","effect":"Hypotension"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"The solution contains electrolytes and glucose that help draw excess fluids and waste products from the blood into the peritoneal cavity, where they can be removed through the dialysis process.","oneSentence":"This solution helps remove waste products from the blood by exchanging fluids in the peritoneal cavity.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:35:28.687Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Peritoneal dialysis for patients with end-stage renal disease"}]},"trialDetails":[{"nctId":"NCT03994471","phase":"PHASE3","title":"Efficacy and Safety of XyloCore Peritoneal Dialysis Solution.","status":"RECRUITING","sponsor":"Iperboreal Pharma Srl","startDate":"2022-12-14","conditions":"End Stage Renal Disease","enrollment":170},{"nctId":"NCT07370441","phase":"PHASE4","title":"Amino Acid (15) Peritoneal Dialysis Solution for Nutritional Improvement in Peritoneal Dialysis Patients","status":"NOT_YET_RECRUITING","sponsor":"Shanghai 10th People's Hospital","startDate":"2026-01-20","conditions":"End-stage Renal Disease (ESRD), Peritoneal Dialysis (PD), Nutritional Status","enrollment":50},{"nctId":"NCT01226550","phase":"PHASE1, PHASE2","title":"Treatment of Primary Peritoneal Carcinosis of Digestive Origin Using Cytoreductive Surgery and Hyperthermic Intraoperative Peritoneal Chemotherapy With Mitomycin C and Irinotecan","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2007-06","conditions":"Peritoneal Carcinosis (PC)","enrollment":18},{"nctId":"NCT04064827","phase":"PHASE3","title":"A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD)","status":"TERMINATED","sponsor":"AbbVie","startDate":"2020-09-16","conditions":"Chronic Kidney Disease (CKD), Secondary Hyperparathyroidism (SHPT)","enrollment":2},{"nctId":"NCT07134595","phase":"NA","title":"Comparing Conventional Continuous Ambulatory Peritoneal Dialysis Prescription (C-CAPD) With Modified-CAPD (M-CAPD) Prescription in Children With End-stage Kidney Disease From Low-resource Settings","status":"RECRUITING","sponsor":"National University Health System, Singapore","startDate":"2024-11-18","conditions":"Children on Chronic Peritoneal Dialysis","enrollment":44},{"nctId":"NCT07077538","phase":"NA","title":"Clinical Study of the Use of Amino Acid Peritoneal Dialysate in Diabetic Patients","status":"RECRUITING","sponsor":"The People's Hospital of Gaozhou","startDate":"2025-07-30","conditions":"Peritoneal Dialysis, Diabetes","enrollment":70},{"nctId":"NCT06358820","phase":"PHASE4","title":"Exploring the Effectiveness and Safety of Amino Acid Peritoneal Dialysis Solution","status":"COMPLETED","sponsor":"The People's Hospital of Gaozhou","startDate":"2023-12-03","conditions":"Exploring the Effectiveness and Safety of Amino Acid Peritoneal Dialysis Solution","enrollment":149},{"nctId":"NCT03994874","phase":"PHASE1, PHASE2","title":"Peritoneal Ultrafiltration in Cardio Renal Syndrome.","status":"RECRUITING","sponsor":"Iperboreal Pharma Srl","startDate":"2025-04-16","conditions":"Congestive Heart Failure","enrollment":84},{"nctId":"NCT06842927","phase":"","title":"Dialysis Efficiency and Transporter Evaluation Computational Tool in Peritoneal Dialysis","status":"ENROLLING_BY_INVITATION","sponsor":"Tuen Mun Hospital","startDate":"2025-03-03","conditions":"End-Stage Kidney Disease, End Stage Renal Disease (ESRD), End Stage Renal Disease on Dialysis (Diagnosis)","enrollment":350},{"nctId":"NCT06492031","phase":"","title":"Observational Study of the Use of Extraneal in Peritoneal Dialysis in Patients","status":"RECRUITING","sponsor":"Vantive Health LLC","startDate":"2024-06-28","conditions":"Chronic Renal Failure","enrollment":889},{"nctId":"NCT00397358","phase":"PHASE4","title":"Effect of Extraneal (Icodextrin)on Triglyceride Levels in PD Patients","status":"WITHDRAWN","sponsor":"Vantive Health LLC","startDate":"2006-11","conditions":"Peritoneal Dialysis, Hypertriglyceridemia","enrollment":""},{"nctId":"NCT00214721","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of an Experimental Solution for Peritoneal Dialysis","status":"COMPLETED","sponsor":"Vantive Health LLC","startDate":"2005-02","conditions":"End Stage Renal Disease","enrollment":120},{"nctId":"NCT00214695","phase":"NA","title":"A Subjective Evaluation of Inflow Pain Associated With the Use of an Experimental Solution for Peritoneal Dialysis","status":"COMPLETED","sponsor":"Vantive Health LLC","startDate":"2005-05","conditions":"End Stage Renal Disease","enrollment":20},{"nctId":"NCT06597201","phase":"PHASE4","title":"Evaluate the Efficacy and Safety of Amino Acid (15) Peritoneal Dialysis Solution in Peritoneal Dialysis Patients with Malnutrition.","status":"RECRUITING","sponsor":"Chengdu Qingshan Likang Pharmaceutical Co., Ltd","startDate":"2024-08-09","conditions":"End Stage Renal Disease (ESRD)","enrollment":400},{"nctId":"NCT06723223","phase":"NA","title":"Novel Combined Function Test for Patients on Peritoneal Dialysis","status":"COMPLETED","sponsor":"Lund University","startDate":"2021-11-02","conditions":"End Stage Kidney Disease (ESRD)","enrollment":34},{"nctId":"NCT06533254","phase":"","title":"Behavioral AI to Predict and Increase Peritoneal Dialysis Uptake","status":"RECRUITING","sponsor":"Scaled Insights","startDate":"2024-09-01","conditions":"Chronic Kidney Disease","enrollment":3000},{"nctId":"NCT05250648","phase":"PHASE4","title":"Clinical Trial on HIPEC with Mitomycin C in Colon Cancer Peritoneal Metastases (GECOP-MMC)","status":"RECRUITING","sponsor":"Hospital Universitario de Fuenlabrada","startDate":"2022-03-02","conditions":"Peritoneal Carcinomatosis, Colon Cancer","enrollment":216},{"nctId":"NCT04086212","phase":"PHASE2","title":"Ultrafiltration Efficacy of a PD Solution Containing Icodextrin-Xylitol-Carnitine","status":"WITHDRAWN","sponsor":"Iperboreal Pharma Srl","startDate":"2019-10-02","conditions":"End Stage Renal Disease (ESRD)","enrollment":""},{"nctId":"NCT06552546","phase":"NA","title":"Pharmacokinetics of Single- and Double-dose Icodextrin","status":"NOT_YET_RECRUITING","sponsor":"Peking University First Hospital","startDate":"2024-08-15","conditions":"Peritoneal Dialysis","enrollment":16},{"nctId":"NCT05721404","phase":"PHASE4","title":"Icodextrin Postpones the Shift of Low Dose to Full Dose Dialysis in the First Year of Incremental Peritoneal Dialysis","status":"RECRUITING","sponsor":"First Affiliated Hospital, Sun Yat-Sen University","startDate":"2023-05-24","conditions":"Peritoneal Dialysis","enrollment":194},{"nctId":"NCT02755610","phase":"NA","title":"Check List to Improve Patient Self-care and Product Defect Report in Continuous Ambulatory Peritoneal Dialysis","status":"UNKNOWN","sponsor":"Chulalongkorn University","startDate":"2016-05-02","conditions":"End-Stage Kidney Disease, Peritonitis","enrollment":880},{"nctId":"NCT05971537","phase":"PHASE4","title":"Clinical Trial on Antibiotic-Lock in Tenckhoff Catheter for Relasping and Repeat Peritonitis","status":"RECRUITING","sponsor":"Alice Ho Miu Ling Nethersole Hospital","startDate":"2023-06-15","conditions":"Peritoneal Dialysis-associated Peritonitis","enrollment":46},{"nctId":"NCT06119373","phase":"NA","title":"Incremental PD With Single Icodextrin Exchange","status":"NOT_YET_RECRUITING","sponsor":"RenJi Hospital","startDate":"2023-12-01","conditions":"Peritoneal Dialysis Complication, Residual Kidney Function, Survival","enrollment":72},{"nctId":"NCT05300191","phase":"","title":"In Vitro Analysis of Effluent Dialysate Solution From Patients on Peritoneal Dialysis, With the CloudCath Device","status":"SUSPENDED","sponsor":"CloudCath","startDate":"2018-09-15","conditions":"Peritoneal Dialysis-associated Peritonitis, End Stage Renal Disease","enrollment":500},{"nctId":"NCT05285436","phase":"NA","title":"A Prospective Clinical Study to Assess the Clinical Utility of Turbidity in Patients Using In-Home Peritoneal Dialysis","status":"UNKNOWN","sponsor":"CloudCath","startDate":"2022-03-16","conditions":"End Stage Renal Disease, Peritoneal Dialysis-associated Peritonitis, Peritonitis","enrollment":314},{"nctId":"NCT05943470","phase":"PHASE4","title":"The Difference Between Daily and Alternative Day Use of Icodextrin","status":"UNKNOWN","sponsor":"RenJi Hospital","startDate":"2023-08-01","conditions":"Peritoneal Dialysis Solution Adverse Reaction","enrollment":74},{"nctId":"NCT05195125","phase":"PHASE1","title":"Use of Direct Peritoneal Resuscitation in High-risk Liver Transplant Recipients","status":"UNKNOWN","sponsor":"University of Colorado, Denver","startDate":"2022-02-01","conditions":"End Stage Liver DIsease, Obesity, Acute Kidney Injury","enrollment":15},{"nctId":"NCT05780086","phase":"PHASE1","title":"Safety of and Tolerability to a Sodium-free Peritoneal Dialysis Solution","status":"UNKNOWN","sponsor":"Instituto Mexicano del Seguro Social","startDate":"2023-02-03","conditions":"Chronic Kidney Diseases","enrollment":10},{"nctId":"NCT04001036","phase":"PHASE2","title":"Efficacy and Safety Assessments of a Peritoneal Dialysis Solution Containing Glucose, Xylitol, and L-Carnitine in CAPD","status":"TERMINATED","sponsor":"Iperboreal Pharma Srl","startDate":"2019-09-01","conditions":"End Stage Renal Disease","enrollment":11},{"nctId":"NCT00436748","phase":"PHASE3","title":"Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Patients With Chronic Kidney Disease","status":"TERMINATED","sponsor":"Amgen","startDate":"2008-09-16","conditions":"Anemia, Chronic Kidney Disease, Kidney Disease","enrollment":116},{"nctId":"NCT04238338","phase":"","title":"Association of MLR With Risk of Death and Cardiovascular Events in PD Patients","status":"UNKNOWN","sponsor":"Zhujiang Hospital","startDate":"2020-06-01","conditions":"Peritoneal Dialysis, Inflammation","enrollment":266},{"nctId":"NCT01779557","phase":"PHASE4","title":"Safety and Effectiveness Evaluation of Two Kinds of Peritoneal Dialysate","status":"COMPLETED","sponsor":"Chinese PLA General Hospital","startDate":"2013-02","conditions":"Kidney Failure,Chronic","enrollment":750},{"nctId":"NCT03205553","phase":"PHASE1","title":"Direct Peritoneal Resuscitation in Gastroschisis","status":"TERMINATED","sponsor":"University of Arkansas","startDate":"2018-02-01","conditions":"Gastroschisis","enrollment":3},{"nctId":"NCT02694068","phase":"","title":"Biological Determinants of Peritoneal Dialysis","status":"COMPLETED","sponsor":"University of Washington","startDate":"2015-09-15","conditions":"End-Stage Kidney Disease","enrollment":4865},{"nctId":"NCT03790176","phase":"PHASE1","title":"ZAVI APD ELF Protocol v2.2","status":"UNKNOWN","sponsor":"Markus Zeitlinger","startDate":"2018-10-01","conditions":"Peritonitis, Pneumonia","enrollment":20},{"nctId":"NCT02791763","phase":"PHASE3","title":"Phase III Study of GSK1278863 in Japanese Non-dialysis (ND) and Peritoneal Dialysis (PD) Subjects With Renal Anemia","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2016-06-06","conditions":"Anaemia","enrollment":355},{"nctId":"NCT01228279","phase":"PHASE4","title":"Sympathetic Activity in Patients With End-stage Renal Disease on Peritoneal Dialysis","status":"COMPLETED","sponsor":"Ottawa Hospital Research Institute","startDate":"2007-07","conditions":"End-stage Renal Disease (ESRD), Kidney Disease","enrollment":50},{"nctId":"NCT04017572","phase":"NA","title":"Optimized vs. Standard Automated Peritoneal Dialysis Regimens Study","status":"COMPLETED","sponsor":"Lund University","startDate":"2019-06-01","conditions":"End Stage Kidney Disease, Chronic Kidney Disease Requiring Chronic Dialysis","enrollment":21},{"nctId":"NCT04427514","phase":"NA","title":"Continuous Ambulatory Peritoneal Dialysis With Telemedicine","status":"UNKNOWN","sponsor":"Szeged University","startDate":"2020-07-01","conditions":"Peritoneal Dialysis, Continuous Ambulatory","enrollment":12},{"nctId":"NCT04394780","phase":"NA","title":"Peritoneal Dialysis Fluid Cooling and Cardio-Protective Effects","status":"COMPLETED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2016-01-11","conditions":"Dialysis; Complications","enrollment":8},{"nctId":"NCT04302649","phase":"PHASE4","title":"Dialysate Temperature in Peritoneal Dialysis","status":"COMPLETED","sponsor":"Azienda Ospedaliero-Universitaria di Modena","startDate":"2018-10-01","conditions":"Peritoneal Dialysis Complication","enrollment":18},{"nctId":"NCT03801226","phase":"EARLY_PHASE1","title":"Zero Sodium Peritoneal Dialysate Protocol Pilot Study","status":"COMPLETED","sponsor":"Yale University","startDate":"2018-12-01","conditions":"Potential Applications for Heart Failure, Volume Overload","enrollment":12},{"nctId":"NCT02909153","phase":"PHASE1","title":"Study of Intraperitoneal Triferic in Patients on Chronic Peritoneal Dialysis","status":"COMPLETED","sponsor":"Rockwell Medical Technologies, Inc.","startDate":"2017-01","conditions":"Peritoneal Dialysis (PD), Anemia, Chronic Kidney Disease","enrollment":30},{"nctId":"NCT00755456","phase":"PHASE2","title":"Effect of an L-carnitine-containing Peritoneal Dialysis (PD) Solution on Insulin Sensitivity in Patients on Continuous Ambulatory Peritoneal Dialysis (CAPD)","status":"COMPLETED","sponsor":"Iperboreal Pharma Srl","startDate":"2008-01","conditions":"End Stage Renal Disease, Insulin Resistance","enrollment":35},{"nctId":"NCT00858182","phase":"PHASE2","title":"Study of Safety and Efficacy on New Peritoneal Dialysis Solutions","status":"WITHDRAWN","sponsor":"Iperboreal Pharma Srl","startDate":"2009-05","conditions":"End-Stage Renal Disease","enrollment":""},{"nctId":"NCT00755404","phase":"PHASE2","title":"Effect of an L-Carnitine-Containing Peritoneal Dialysis (PD) Solution on Insulin Sensitivity in Diabetic Patients on Continuous Ambulatory Peritoneal Dialysis (CAPD)","status":"WITHDRAWN","sponsor":"Iperboreal Pharma Srl","startDate":"2007-06","conditions":"End Stage Renal Disease, Diabetes","enrollment":""},{"nctId":"NCT00851838","phase":"PHASE2","title":"L-Carnitine as an Osmo-metabolic Agent for Peritoneal Dialysis","status":"COMPLETED","sponsor":"Iperboreal Pharma Srl","startDate":"2009-06","conditions":"End-Stage Renal Disease","enrollment":5},{"nctId":"NCT02846337","phase":"NA","title":"Ultrafiltration Versus Medical Therapies in the Management of the Cardio Renal Syndrome","status":"UNKNOWN","sponsor":"Hospices Civils de Lyon","startDate":"2017-03-31","conditions":"Cardio-renal Syndrome","enrollment":154},{"nctId":"NCT03189316","phase":"NA","title":"Anti-inflammatory Cells in Peritoneal Cavity","status":"TERMINATED","sponsor":"University Hospital, Montpellier","startDate":"2017-06-06","conditions":"Ovarian Cysts, Chronic Renal Insufficiency","enrollment":10},{"nctId":"NCT03190018","phase":"NA","title":"A Feasibility Study of Peritoneal Dialysis With CLS PD, Which Removes Toxins and Maintains a Stable Ultrafiltration by Continuously Regenerating a Recirculating Intraperitoneal Fluid, in Patients With End Stage Renal Disease, ESRD, With PD Therapy.","status":"COMPLETED","sponsor":"Triomed AB","startDate":"2017-06-01","conditions":"Peritoneal Dialysis","enrollment":5},{"nctId":"NCT01242904","phase":"PHASE2","title":"Use of a Bimodal Solution for Peritoneal Dialysis","status":"COMPLETED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2010-09-30","conditions":"End Stage Renal Disease","enrollment":36},{"nctId":"NCT02772146","phase":"NA","title":"A Clinical Study of the Safety and Efficacy of a Wearable Device (CLS UF) That Delivers Continuous Administration of Glucose to Recirculated Peritoneal Dialysis Fluid for the Purpose of Ultrafiltration in Patients With Congestive Heart Failure","status":"TERMINATED","sponsor":"Triomed AB","startDate":"2016-05-11","conditions":"Heart Failure, Cardio-Renal Syndrome","enrollment":2},{"nctId":"NCT00912821","phase":"PHASE4","title":"Effect of Different Dialysis Dosage on Prognosis in Maintenance Peritoneal Dialysis Patients","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2009-03","conditions":"End-stage Renal Disease","enrollment":200},{"nctId":"NCT01044446","phase":"PHASE4","title":"Effect of Icodextrin on the Treatment Outcome of Peritoneal Dialysis Patients During Acute Peritonitis","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2010-01","conditions":"Peritonitis","enrollment":56},{"nctId":"NCT01753154","phase":"PHASE4","title":"The Effect of Balance PD Solution on the Peritoneal Membrane in Patients on Automated Peritoneal Dialysis","status":"COMPLETED","sponsor":"Fresenius Medical Care Deutschland GmbH","startDate":"2011-07","conditions":"Chronic Renal Failure","enrollment":25},{"nctId":"NCT01170858","phase":"NA","title":"Effect of Icodextrin Solution on Preservation of Residual Renal Function in Patients on Peritoneal Dialysis","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2010-08","conditions":"End Stage Renal Disease","enrollment":100},{"nctId":"NCT01353638","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of the Addition of Alanyl-Glutamine-Dipeptide to Dialysis Solution in Peritoneal Dialysis","status":"TERMINATED","sponsor":"Christoph Aufricht","startDate":"2011-04","conditions":"End Stage Renal Disease","enrollment":25},{"nctId":"NCT00776191","phase":"PHASE4","title":"Randomized Multicenter Cross-over Study to Compare the Effect of Physioneal 35 to 40 on the Protein Metabolism","status":"TERMINATED","sponsor":"University of Erlangen-Nürnberg Medical School","startDate":"2008-09","conditions":"Endstage Renal Disease","enrollment":5},{"nctId":"NCT02446158","phase":"PHASE4","title":"Daily Chlorhexidine Care at the Exit Site in Peritoneal Dialysis Patients","status":"COMPLETED","sponsor":"E-DA Hospital","startDate":"2010-05","conditions":"Peritoneal Dialysis Catheter Exit Site Infection","enrollment":89},{"nctId":"NCT02393261","phase":"NA","title":"A Controlled and Multi-Center Study of 2500ml Huaren Peritoneal Dialysate","status":"UNKNOWN","sponsor":"Sun Yat-sen University","startDate":"2015-01","conditions":"Disorders Associated With Peritoneal Dialysis","enrollment":300},{"nctId":"NCT00794326","phase":"PHASE3","title":"Clinical Evaluation of Low Sodium Peritoneal Dialysis (PD) Solution on Hypertensive Patients Treated With PD","status":"COMPLETED","sponsor":"Fresenius Medical Care Deutschland GmbH","startDate":"2008-10","conditions":"Chronic Kidney Failure","enrollment":140},{"nctId":"NCT01021878","phase":"PHASE4","title":"Study to Evaluate the Effects Icodextrin Versus Dianeal on Insulin Resistance in Nondiabetic Automated Peritoneal Dialysis Patients","status":"COMPLETED","sponsor":"Pontifícia Universidade Católica do Paraná","startDate":"2009-10","conditions":"Disorders Associated With Peritoneal Dialysis","enrollment":60},{"nctId":"NCT00966615","phase":"PHASE4","title":"The Effect of Neutral Peritoneal Dialysis (PD) Solution With Minimal Glucose-Degradation-Product (GDP) on Fluid Status and Body Composition","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2010-09","conditions":"Renal Failure, ESRD, Cardiovascular Disease","enrollment":68},{"nctId":"NCT01292863","phase":"NA","title":"The Impact of Delflex on Mesothelial Cell Viability and Peritoneal Transport","status":"WITHDRAWN","sponsor":"University of North Carolina, Chapel Hill","startDate":"2011-03","conditions":"End Stage Renal Disease","enrollment":""},{"nctId":"NCT01632046","phase":"PHASE4","title":"Administration of pH-Neutral Peritoneal Dialysis Solutions Containing Lactate or Bicarbonate in Children","status":"COMPLETED","sponsor":"Heidelberg University","startDate":"2004-03","conditions":"Chronic Renal Failure, Peritoneal Membrane Disorder","enrollment":42},{"nctId":"NCT01315314","phase":"PHASE4","title":"Effect of Glucose Degradation Products (GDP) on Endothelial Dysfunction","status":"COMPLETED","sponsor":"Kyungpook National University Hospital","startDate":"2005-10","conditions":"Kidney Failure, Chronic, Disorders Associated With Peritoneal Dialysis","enrollment":146},{"nctId":"NCT00922701","phase":"PHASE2","title":"L-Carnitine in Peritoneal Dialysis","status":"COMPLETED","sponsor":"Iperboreal Pharma Srl","startDate":"2004-06","conditions":"End-Stage Renal Disease","enrollment":4},{"nctId":"NCT00119990","phase":"NA","title":"Changes in Cardiovascular Hemodynamics During Peritoneal Dialysis","status":"TERMINATED","sponsor":"University of Aarhus","startDate":"2006-01","conditions":"Peritoneal Dialysis","enrollment":15},{"nctId":"NCT00725517","phase":"PHASE4","title":"Efficacy and Safety of a 7.5% Icodextrin Peritoneal Dialysis Solution in Once-Daily Long Dwell Exchange","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2005-12","conditions":"Chronic Kidney Disease, Peritoneal Dialysis","enrollment":2},{"nctId":"NCT00173056","phase":"","title":"The Factors Predicting Change of Peritoneal Transport Characters in Peritoneal Dialysate","status":"UNKNOWN","sponsor":"National Taiwan University Hospital","startDate":"","conditions":"Peritoneal Fibrosis","enrollment":""},{"nctId":"NCT00173485","phase":"","title":"The Study of Infection and Cell Inflammation in Peritoneal Dialysate","status":"UNKNOWN","sponsor":"National Taiwan University Hospital","startDate":"2005-06","conditions":"Peritonitis, Kidney Failure","enrollment":100}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Solution for Peritoneal Dialysis","genericName":"Solution for Peritoneal Dialysis","companyName":"Fresenius Medical Care Deutschland GmbH","companyId":"fresenius-medical-care-deutschland-gmbh","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This solution helps remove waste products from the blood by exchanging fluids in the peritoneal cavity. Used for Peritoneal dialysis for patients with end-stage renal disease.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}